Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Stockholders Equity of $245.15 million for the year ending 2025.
- Tonix Pharmaceuticals Holding Corp. showed an increase of +75.7% in Stockholders Equity from 2024 to 2025.
- This data is from Tonix Pharmaceuticals Holding Corp.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$639.7 thousand | Q2 2013: -$1.96 million | Q3 2013: $5.44 million | Q1 2014: $47.92 million | Q2 2014: $42.66 million | Q3 2014: $43.78 million | Q1 2015: $56.89 million | Q2 2015: $46.24 million | Q3 2015: $52.65 million | Q1 2016: $27.34 million | Q2 2016: $30.03 million | Q3 2016: $27.11 million | Q1 2017: $21.98 million | Q2 2017: $33.97 million | Q3 2017: $28.68 million | Q1 2018: $18.61 million | Q2 2018: $15.84 million | Q3 2018: $13.71 million | Q1 2019: $17.81 million | Q2 2019: $12.82 million | Q3 2019: $9.86 million | Q1 2020: $31.25 million | Q2 2020: $53.57 million | Q3 2020: $62.57 million | Q1 2021: $176.92 million | Q2 2021: $180.49 million | Q3 2021: $202.22 million | Q1 2022: $207.96 million | Q2 2022: $228.28 million | Q3 2022: $228.92 million | Q1 2023: $165.43 million | Q2 2023: $140.46 million | Q3 2023: $120.83 million | Q1 2024: $108.14 million | Q2 2024: $42.10 million | Q3 2024: $74.21 million | Q1 2025: $180.40 million | Q2 2025: $168.00 million | Q3 2025: $231.14 million.
- Over the full 19 years of available data (2007 to 2025), Tonix Pharmaceuticals Holding Corp.'s Stockholders Equity has grown by 59,127.6%.
- Historical annual values: Fiscal year 2025: $245.15 million | Fiscal year 2024: $139.56 million | Fiscal year 2023: $105.53 million | Fiscal year 2022: $207.18 million | Fiscal year 2021: $218.72 million | Fiscal year 2020: $87.65 million | Fiscal year 2019: $9.42 million | Fiscal year 2018: $23.66 million | Fiscal year 2017: $24.62 million | Fiscal year 2016: $25.36 million | Fiscal year 2015: $40.26 million | Fiscal year 2014: $36.09 million | Fiscal year 2013: $6.51 million | Fiscal year 2012: $959.0 thousand | Fiscal year 2011: -$2.45 million | Fiscal year 2010: -$175.0 thousand | Fiscal year 2009: -$537.0 thousand | Fiscal year 2008: -$545.0 thousand | Fiscal year 2007: -$415.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: